Drug Profile
FF 10102 01
Alternative Names: FF-10102-01Latest Information Update: 28 Jan 2021
Price :
$50
*
At a glance
- Originator FUJIFILM Corporation
- Class Antineoplastics
- Mechanism of Action Syk kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders; Haematological malignancies
Most Recent Events
- 28 Jan 2021 No recent reports of development identified for preclinical development in Autoimmune-disorders in Japan (PO)
- 28 Jan 2021 No recent reports of development identified for preclinical development in Haematological-malignancies in Japan (PO)
- 03 Dec 2016 Preclinical trials in Autoimmune disorders and Haematological malignancies in Japan (PO)